RUA Life Sciences plc (AIM:RUA)
London
· Delayed Price · Currency is GBP · Price in GBX 13.75
0.00 (0.00%)
At close: Feb 27, 2026
RUA Life Sciences Income Statement
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2021 - 2017 |
| Operating Revenue | 4.46 | 4.11 | 2.19 | 2.18 | 1.63 | Upgrade
|
| Revenue | 4.46 | 4.11 | 2.19 | 2.18 | 1.63 | Upgrade
|
| Revenue Growth (YoY) | 8.42% | 87.72% | 0.55% | 34.09% | 6.35% | Upgrade
|
| Cost of Revenue | 1 | 0.94 | 0.48 | 0.45 | 0.35 | Upgrade
|
| Gross Profit | 3.46 | 3.17 | 1.72 | 1.73 | 1.27 | Upgrade
|
| Selling, General & Admin | 3.53 | 4.16 | 2.48 | 2.61 | 2.17 | Upgrade
|
| Research & Development | 0.29 | - | 0.87 | 1.07 | 0.91 | Upgrade
|
| Other Operating Expenses | -0.64 | -0.97 | -0.06 | -0.01 | 0.22 | Upgrade
|
| Operating Expenses | 3.63 | 3.19 | 3.65 | 4.03 | 3.62 | Upgrade
|
| Operating Income | -0.17 | -0.02 | -1.94 | -2.31 | -2.35 | Upgrade
|
| Interest Expense | - | - | -0.08 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.16 | -0.01 | -2.02 | -2.32 | -2.36 | Upgrade
|
| Pretax Income | -0.16 | -0.01 | -2.02 | -2.32 | -2.36 | Upgrade
|
| Income Tax Expense | -0 | -0.01 | -0.58 | -0.32 | -0.29 | Upgrade
|
| Earnings From Continuing Operations | -0.16 | 0 | -1.44 | -2 | -2.07 | Upgrade
|
| Minority Interest in Earnings | 0.01 | - | - | - | - | Upgrade
|
| Net Income | -0.15 | 0 | -1.44 | -2 | -2.07 | Upgrade
|
| Net Income to Common | -0.15 | 0 | -1.44 | -2 | -2.07 | Upgrade
|
| Shares Outstanding (Basic) | 62 | 62 | 34 | 22 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 62 | 62 | 34 | 22 | 22 | Upgrade
|
| Shares Change (YoY) | - | 85.00% | 51.21% | - | 25.36% | Upgrade
|
| EPS (Basic) | -0.00 | 0.00 | -0.04 | -0.09 | -0.09 | Upgrade
|
| EPS (Diluted) | -0.00 | 0.00 | -0.04 | -0.09 | -0.09 | Upgrade
|
| Free Cash Flow | -0.24 | -0.28 | -1.38 | -1.6 | -3.26 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.04 | -0.07 | -0.15 | Upgrade
|
| Gross Margin | 77.50% | 77.12% | 78.32% | 79.30% | 78.22% | Upgrade
|
| Operating Margin | -3.84% | -0.49% | -88.41% | -105.83% | -144.74% | Upgrade
|
| Profit Margin | -3.26% | 0.02% | -65.72% | -91.92% | -127.20% | Upgrade
|
| Free Cash Flow Margin | -5.29% | -6.83% | -63.12% | -73.20% | -200.43% | Upgrade
|
| EBITDA | 0.27 | 0.4 | -1.57 | -1.95 | -2.04 | Upgrade
|
| EBITDA Margin | 6.10% | 9.75% | -71.79% | -89.40% | -125.72% | Upgrade
|
| D&A For EBITDA | 0.44 | 0.42 | 0.36 | 0.36 | 0.31 | Upgrade
|
| EBIT | -0.17 | -0.02 | -1.94 | -2.31 | -2.35 | Upgrade
|
| EBIT Margin | -3.84% | -0.49% | -88.41% | -105.83% | -144.74% | Upgrade
|
| Advertising Expenses | - | - | 0.01 | 0.02 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.